What is it about?
oral tablet therapy of 25mg etoposide
Featured Image
Why is it important?
low cost and few side-effects and easy therapy for poor performance patients
Perspectives
This case my be rare, but it was useful for the patient.
Yasuhiko NAKAMURA
Yamaguchi Prefectural Grand Medical Center
Read the Original
This page is a summary of: Remarkable response of recurrent endometrial adenocarcinoma to daily oral administration of half-dose etoposide, SAGE Open Medical Case Reports, January 2018, SAGE Publications,
DOI: 10.1177/2050313x18819599.
You can read the full text:
Contributors
The following have contributed to this page
